Skip to main content
. 2014 Mar 30;2014(3):CD005195. doi: 10.1002/14651858.CD005195.pub3

RCT_Cheng 2003

Trial name or title Selenium Supplementation for the Prevention of Hepatocellular Carcinomas in HBsAg Positive Patients (pilot study)
Methods Randomised controlled trial
Participants Men 45 to 64 years of age with positive HBsAg test, negative AFP test and normal ALT values
Interventions Placebo or 200 mg (sic!)/d selenium as selenised yeast
Outcomes Primary liver cancer
Starting date 2003
Contact information Prof Kar Keung Cheng, University of Birmingham, UK
Notes Study author contacted for further information, but no reply received
Should probably say 200 µg/d selenium yeast as intervention in the publication